GRAL Share Price Performance
US$65.55
52.75 (412.07%)
61.8% overvalued intrinsic discount
US$40.50
Fair Value
Price US$65.55
AnalystConsensusTarget US$40.50
Fair ValueUS$56.50
Share PriceUS$65.55
16.0% overvalued intrinsic discount
GRAIL, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
GRAL Community Narratives
AN
Fair Value US$56.5 16.0% overvalued intrinsic discount
FDA Approval And NHS Studies Will Transform Cancer Detection
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
Recent GRAL News & Updates
GRAIL, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -12.29
- Gross Margin
- -56.53%
- Net Profit Margin
- -329.86%
- Debt/Equity Ratio
- 0%
GRAIL, Inc. Competitors
Snowflake Analysis
About GRAL
- Founded
- 2015
- Employees
- 1000
- CEO
- WebsiteView website
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 0.9%
- 3 Months: 8.7%
- 1 Year: 18.4%
- Year to Date: 14.8%
The market is up 1.2% over the last week, with the Information Technology sector leading the way, up 2.4%. As for the past 12 months, the market is up 18%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›